Physician profile
Sharon Dragich
NPI 1730594821
$1,220.32
in general payments reported to CMS, 2019-2025
17 companies · $637 in 2025
The $637 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.93 · 2021: $63.10 · 2022: $12.08 · 2023: $309 · 2024: $99.72 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.21 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $326.90 | 2023-2025 | Apretude |
| Astellas Pharma US INC | $290.53 | 2025 | Veozah |
| Exeltis, USA INC. | $95.90 | 2023-2024 | Slynd |
| Organon LLC | $75.90 | 2023-2025 | Nexplanon |
| Myovant Sciences INC. | $63.10 | 2021 | |
| Exact Sciences Corporation | $61.69 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $46.47 | 2019 | |
| Abbvie INC. | $44.55 | 2023 | Ubrelvy, Liletta |
| Sumitomo Pharma America, INC. | $39.87 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $33.32 | 2024-2025 | |
| Allergan, INC. | $29.06 | 2019 | |
| Duchesnay USA Incorporated | $23.40 | 2019 | |
| Glaxosmithkline, LLC. | $22.28 | 2025 | Bexsero, Arexvy, Shingrix |
| Coopersurgical, INC. | $19.91 | 2025 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $19.18 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $16.18 | 2025 | Voquezna |
| Scilex Pharmaceuticals INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Dragich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.